ALSEN — Sensorion SA Share News
0.000.00%
Last trade - 00:00Brief: Sensorion Appoints Khalil Barrage as Board's Interim Chairman
French and Benelux stocks-Factors to watch
French biotech Sensorion does not expect any impact to its liquidity from SVB's closure
Brief: Sensorion Appoints David Lawrence As CFO
Brief: Sensorion, Eveon Collaborate To Develop Injection System For Delivery Of Gene Therapy Treatments Into Inner Ear
Brief: Sensorion/Sens-401: First Patient Enrolled In Phase 2A Proof Of Concept Clinical Trial In Cisplatin-Induced Ototoxicity
Brief: Sensorion Receives FDA'S Orphan Drug Designation For OTOF-GT
Brief: Sensorion/OTOF-GT: FDA Grants Pediatric Disease Designation For Treatment Of Otoferlin Gene-Mediated Hearing Loss
Brief: Sensorion: Approval For Amended Phase 2A Proof Of Concept Trial Of Sens-401 In Cisplatin-Induced Ototoxicity In France
Europe Research Roundup: Aselsan, Prudential, Tatton Asset Management
Brief: Sensorion End-June Operating Loss Widens To EUR 12.2 Mln
Brief: Sensorion: First Patient Enrolled In Sens-401 Trial For Residual Hearing Preservation During Cochlear Implantation
Brief: Sensorion Receives Positive Opinion For Orphan Drug Designation For OTOF-GT From EMA
Brief: Sensorion Announces Australian Approval For PoC Trial Of Sens-401
Brief: Sensorion Allowed To Start SENS-401 PoC Clinical Trial In France
Brief: Sensorion Sa Cash Position Of Eur 50 Million At Year-End
Brief: Sensorion Provides Update On SENS-401
Brief: Sensorion To Present New Data On OTOF Gene Therapy
Brief: Sensorion Updates On SENS-401 Phase 2 Trial In Sudden Sensorineural Hearing Loss